EU eyes autumn approval of Pfizer jab for COVID variants
The EU's medicines watchdog said Wednesday it aims to approve this autumn a Pfizer/BioNTech COVID vaccine adapted for two fast-spreading subvariants of the Omicron strain.
Aug 10, 2022
0
50
Biological Factors: News and Research on BNT162 Vaccine
MeSH tree: D23.050.865.450.500.750
Third, fourth COVID-19 vaccine doses boost humoral response in seniors
Third and fourth BNT162b2 vaccine doses in adults aged 60 years or older are associated with a significant increase in antispike (anti-S) immunoglobulin G (IgG) antibody titers, according to a research letter published online ...
Jul 27, 2022
0
49
A third COVID-19 booster is crucial to identifying and fighting new variants
Twenty different COVID-19 variants were effectively identified and neutralized after a third booster, according to the new study for which the University of Surrey provided the crucial antigenic map of variants of concern.
Jul 25, 2022
0
236
Researchers track cellular and antibody responses to COVID-19 vaccine
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Jul 22, 2022
0
100
What's known about Biden catching COVID-19?
President Joe Biden tested positive for COVID-19 on Thursday, is experiencing mild symptoms and has begun taking Paxlovid, an antiviral pill treatment.
Jul 22, 2022
0
33
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven ...
Jul 21, 2022
0
197
COVID vaccines averted infection in 10% of patient-facing healthcare staff during second wave
The rapid COVID-19 vaccine rollout from December 2020 averted infection in a large proportion of NHS hospital workers in England during the second wave of the pandemic, suggests research published by The BMJ today.
Jul 20, 2022
0
69
Valneva suspends Covid vaccine production as EU shrinks order
COVID vaccine producer Valneva suspended production on Wednesday after the European Commission massively ramped down a planned order of millions of doses.
Jul 20, 2022
0
66
Adverse reactions to BNT162b2 mild, moderate for 5- to 11-year-olds
Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in Pediatrics.
Jul 11, 2022
0
43
Study reports broadly neutralizing antibody protects hamsters against SARS-CoV-2 omicron variants
Structural biologists at The Hong Kong University of Science and Technology (HKUST) together with researchers at the AIDS Institute, The University of Hong Kong (HKU), Department of Microbiology, School of Clinical Medicine, ...
Jul 11, 2022
0
70
